Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type II Diabetes Control”

3,678 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,678 results

Large-scale testing (Phase 3)Study completedNCT01730534
What this trial is testing

Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events

Who this might be right for
Diabetes Mellitus, Non-Insulin-DependentHigh Risk for Cardiovascular Event
AstraZeneca 17,190
Testing effectiveness (Phase 2)UnknownNCT06558708
What this trial is testing

A Trial Comparing Efficacy, Tolerability, and Safety of GZR101 Injection Once Daily (OD) and GZR33-70 Injection OD

Who this might be right for
Type 2 Diabetes
Gan and Lee Pharmaceuticals, USA 60
Not applicableStudy completedNCT02082184
What this trial is testing

An Evaluation of a Novel Glucose Sensing Technology in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Abbott Diabetes Care 302
Early research (Phase 1)Looking for participantsNCT07399678
What this trial is testing

Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D

Who this might be right for
Overweight or Obese AdultsOverweight or Obese, Type 2 Diabetes
Alveus Therapeutics, Inc. 180
Post-approval studies (Phase 4)Ended earlyNCT00936663
What this trial is testing

Using Sitagliptin as a Treatment to Prevent New Onset Diabetes After Kidney Transplantation

Who this might be right for
Type 2 DiabetesEnd Stage Renal Disease
University of Nebraska 3
Large-scale testing (Phase 3)Not Yet RecruitingNCT07628985
What this trial is testing

BALANCE-DM2 Study of Bofanglutide in Adults With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Carnot Laboratories 374
Testing effectiveness (Phase 2)Study completedNCT06849843
What this trial is testing

3mg Once Every Two Weeks Administration of Efsubaglutide Alfa Injection in Type 2 Diabetes Patients.

Who this might be right for
Type2 Diabetes
Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. 59
Testing effectiveness (Phase 2)Ended earlyNCT00982293
What this trial is testing

The Application of Extremely Low Level Magnetic Fields as Adjunctive Treatment for Type II Diabetes

Who this might be right for
Type 2 Diabetes
pico-tesla Magnetic Therapies, LLC 165
Early research (Phase 1)Ended earlyNCT00332085
What this trial is testing

Pilot Trial of Chromium-Metformin Combination in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Bastyr University 40
Large-scale testing (Phase 3)UnknownNCT04667143
What this trial is testing

Dual Add-on Therapy in Type 2 Diabetes Poorly Controlled With Metformin Monotherapy

Who this might be right for
Diabetes Mellitus, Type II
Jiangsu HengRui Medicine Co., Ltd. 760
Testing effectiveness (Phase 2)UnknownNCT03279263
What this trial is testing

An Add-on Study of MLR-1023 in Adults With Uncontrolled Type 2 Diabetes on Metformin Therapy

Who this might be right for
Type 2 Diabetes Mellitus
Melior Pharmaceuticals 400
Not applicableStudy completedNCT02185755
What this trial is testing

Internet Monitoring vs Medication to Control Blood Sugar in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Endocrine Research Society 60
Not applicableStudy completedNCT03644134
What this trial is testing

A Personalized Intervention to Manage Physiological Stress and Improve Sleep Patterns

Who this might be right for
Type 2 Diabetes Mellitus
Rashid Centre for Diabetes and Research 51
Large-scale testing (Phase 3)Study completedNCT01179048
What this trial is testing

Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 9,341
Large-scale testing (Phase 3)Study completedNCT01076647
What this trial is testing

Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 467
Early research (Phase 1)Study completedNCT07020949
What this trial is testing

Multiple Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of THDBH120 in Chinese Patients With T2DM

Who this might be right for
Diabetes Mellitus Type 2
Tonghua Dongbao Pharmaceutical Co.,Ltd 49
Large-scale testing (Phase 3)Study completedNCT01811485
What this trial is testing

Study of Efficacy and Safety LMF237 in Patients With Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled With Vildagliptin Monotherapy

Who this might be right for
Diabetes Mellitus, Type 2
Novartis Pharmaceuticals 171
Not applicableStudy completedNCT06376240
What this trial is testing

The Effect of Pyridoxamine Supplementation on Microvascular Function in Type 2 Diabetes

Who this might be right for
Type 2 DiabetesMicrovascular FunctionRetinopathy, Diabetic+2 more
Maastricht University Medical Center 40
Large-scale testing (Phase 3)Study completedNCT00315718
What this trial is testing

Long-Term Effects of Sucontral(TM) on Mild and Moderate Cases of Diabetes Mellitus (Type 2)

Who this might be right for
Diabetes Mellitus, Type 2
Harras Pharma Curarina GmbH 10
Post-approval studies (Phase 4)Study completedNCT05167513
What this trial is testing

Monitoring Parameters Beyond Glycemic Control: Impact of Sitagliptin on Quality of Life in Type 2 Diabetes Patients

Who this might be right for
Quality of LifeType 2 DiabetesMetformin+Sitagliptin
Getz Pharma 188
Next Page